Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020)

Historic Non-Current Deffered Revenue for CV Sciences (CVSI) over the last 3 years, with Q4 2020 value amounting to $1.5 million.

  • CV Sciences' Non-Current Deffered Revenue changed N/A to $1.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2020, which is N/A changed from last year.
  • Per CV Sciences' latest filing, its Non-Current Deffered Revenue stood at $1.5 million for Q4 2020.
  • In the past 5 years, CV Sciences' Non-Current Deffered Revenue ranged from a high of $1.5 million in Q4 2020 and a low of $1.1 million during Q4 2017
  • In the last 3 years, CV Sciences' Non-Current Deffered Revenue had a median value of $1.3 million in 2018 and averaged $1.3 million.
  • Data for CV Sciences' Non-Current Deffered Revenue shows a peak YoY increase of 2443.82% (in 2018) and a maximum YoY decrease of 2443.82% (in 2018) over the last 5 years.
  • Quarter analysis of 3 years shows CV Sciences' Non-Current Deffered Revenue stood at $1.1 million in 2017, then rose by 24.44% to $1.3 million in 2018, then rose by 9.33% to $1.5 million in 2020.
  • Its last three reported values are $1.5 million in Q4 2020, $1.3 million for Q4 2018, and $1.1 million during Q4 2017.